首页> 外国专利> DEPLETION OF CELLS RESPONSIBLE FOR ANTIBODY-MEDIATED GRAFT REJECTION

DEPLETION OF CELLS RESPONSIBLE FOR ANTIBODY-MEDIATED GRAFT REJECTION

机译:抗体介导的移植排斥反应中细胞的耗竭

摘要

The present invention provides compositions, and methods of using said compositions, which are useful to reduce allogeneic or xenogeneic graft rejection. The invention provides methods and compositions for promoting in an animal of a first species a state of tolerance against Gal alpha 1,3Gal epitopes present on a xenograft from an animal of a second species, thereby preventing hyperacute rejection (HAR) of the xenograft. The methods and compositions according to the invention cause the elimination or anergy of specific lymphoid cells which are responsible for the production of xenoreactive natural antibodies (XNAs) which cause HAR of the xenograft. The invention also provides immunotoxin compositions and methods of using the same which are useful to reduce allogeneic or xenogeneic antibody-mediated graft rejection. The methods and compositions according to the invention cause the reduction or elimination of specific cells responsible for the production of antibodies that cause graft rejection.
机译:本发明提供了可用于减少同种异体或异种移植排斥的组合物和使用所述组合物的方法。本发明提供了用于在第一物种的动物中促进对来自第二物种的动物的异种移植物中存在的Gal alpha 1,3Gal表位的耐受状态,从而防止异种移植物的超急性排斥(HAR)的方法和组合物。根据本发明的方法和组合物引起特定淋巴样细胞的消除或无反应,所述特异性淋巴样细胞负责产生引起异种移植物的HAR的异种反应性天然抗体(XNA)。本发明还提供了可用于减少同种或异种抗体介导的移植排斥的免疫毒素组合物及其使用方法。根据本发明的方法和组合物引起负责产生引起移植排斥的抗体的特异性细胞的减少或消除。

著录项

  • 公开/公告号WO0006194A9

    专利类型

  • 公开/公告日2001-12-13

    原文格式PDF

  • 申请/专利权人 BIOTRANSPLANT INC.;THALL AROU;

    申请/专利号WO1999US17190

  • 发明设计人 THALL AROU;

    申请日1999-07-29

  • 分类号C07K16/28;A61K47/48;

  • 国家 WO

  • 入库时间 2022-08-22 00:38:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号